Changes of Serum S100B Protein, NT-3 and GFAP Levels in Patients with First-episode Schizophrenia and Their Relationships with Cognitive Function and Prognosis

SHI Xinyi, CHONG Xiaoni, LU Mei

PDF(1185 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1185 KB)
Labeled Immunoassays and Clinical Medicine ›› 2024, Vol. 31 ›› Issue (1) : 94-98. DOI: 10.11748/bjmy.issn.1006-1703.2024.01.016
Clinical Investigation

Changes of Serum S100B Protein, NT-3 and GFAP Levels in Patients with First-episode Schizophrenia and Their Relationships with Cognitive Function and Prognosis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 31(1): 94-98 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.01.016

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1185 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉